VAERS reports by lot
Sanofi Pasteur DTaP/Tdap lot U4646AA: VAERS reports
29 VAERS reports list lot U4646AA as a Sanofi Pasteur DTaP/Tdap vaccine, received between 2013-06-17 and 2015-06-02. Data: VAERS public files through 28 May 2026 (site extract 2026-10-28).
Symptom categories in these reports
A report can mention several categories, so the counts add up to more than the number of reports.
| Category | Count | % |
|---|---|---|
| Injection-site / Local reaction | 32 | 36% |
| General / Systemic (non-local) | 15 | 17% |
| Musculoskeletal | 10 | 11% |
| Neurological | 9 | 10% |
| Respiratory | 5 | 6% |
| Gastrointestinal | 5 | 6% |
| Cardiac / Cardiovascular | 4 | 5% |
| Allergic / Anaphylactic | 4 | 5% |
| Dermatological (non-injection-site) | 3 | 3% |
| Psychiatric / Neuropsychiatric | 1 | 1% |
Where reports came from
U.S. state of the reporter, where given (top 12).
| State | Reports |
|---|---|
| South Carolina | 6 |
| Maryland | 3 |
| Missouri | 3 |
| Georgia | 2 |
| New Jersey | 1 |
| Wisconsin | 1 |
| California | 1 |
| Michigan | 1 |
| Massachusetts | 1 |
| Florida | 1 |
| Nebraska | 1 |
| North Carolina | 1 |
Reports by month received
| Month | Reports | Bar |
|---|---|---|
| 2013-06 | 1 | |
| 2013-07 | 6 | |
| 2013-08 | 6 | |
| 2013-09 | 1 | |
| 2013-11 | 3 | |
| 2013-12 | 1 | |
| 2014-09 | 1 | |
| 2015-01 | 9 | |
| 2015-06 | 1 |
Products recorded with this lot
- Tdap — Sanofi Pasteur (29 reports)
Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.
Related
- All Sanofi Pasteur DTaP/Tdap lots with VAERS reports
- DTaP/Tdap vaccine lot number lookup
- DTaP/Tdap vaccine side effects, trials and ingredients
- Daptacel: ingredients, package insert and side effects
- Look up a lot for any vaccine
Nearby Sanofi Pasteur DTaP/Tdap lots (A–Z): U4612AA · U4617AA · U4618AA · U4655AA · U4700BA · U4804AA
Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-10-28 18:08 UTC. Not medical advice. Report errors via contact.